Page last updated: 2024-08-05 10:53:15
dimethylaniline
A methylaniline carrying at least two methyl groups.
ChEBI ID: 23806
Members (7)
| Member | Definition | Role |
|---|---|---|
| 2,4-xylidine | A primary arylamine that is aniline in which the hydrogens at the 2- and 4-positions are replaced by methyl groups. A clear to yellow liquid, it is used in production of certain dyes, pesticides and other chemicals. | 2,4-dimethylaniline |
| 2,5-xylidene | A primary arylamine that is aniline in which the hydrogens at the 2- and 5-positions are replaced by methyl groups. It is used in the manufacture of dyes and other chemicals. | 2,5-dimethylaniline |
| 2,6-xylidine | A primary arylamine that is aniline in which the hydrogens at the 2- and 6-positions are replaced by methyl groups. It is used in the production of some anasthetics and other chemicals. It is a drug metabolite of lidocaine (local anasthetic). | 2,6-dimethylaniline |
| 3,4-xylidine | A primary arylamine that is aniline in which the hydrogens at the 3- and 4-positions are replaced by methyl groups. A low-melting, crystalline solid, it is used in the production of vitamin B2, dyes, pesticides and other chemicals. | 3,4-dimethylaniline |
| 4-nitrosodimethylaniline | A member of the class of dimethylanilines that is N,N-dimethylaniline having a nitroso group at the 4-position. | N,N-dimethyl-4-nitrosoaniline |
| dimethylaniline n-oxide | A member of the class of dimethylanilines that is N,N-dimethylaniline in which the tertiary amino group has been oxidised to give the corresponding N-oxide. | N,N-dimethylaniline N-oxide |
| n,n-dimethylaniline | A tertiary amine that is aniline in which the amino hydrogens are replaced by two methyl groups. | N,N-dimethylaniline |
Research
Studies (370)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 67 (18.11) | 18.7374 |
| 1990's | 94 (25.41) | 18.2507 |
| 2000's | 120 (32.43) | 29.6817 |
| 2010's | 74 (20.00) | 24.3611 |
| 2020's | 15 (4.05) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 9 (2.16%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 407 (97.84%) | 84.16% |